The Use of Ultrasound in Assessing Post-prostatectomy Erectile Dysfunction
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT05109208
- Status
- Recruiting
Conditions
- Prostate Adenocarcinoma
Eligibility Criteria
- Sex
- MALE
- Age
- 40 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Ulrasound Vibroelastography (UVE) — DIAGNOSTIC_TESTUltrasound technique to quantitatively assess tissue stiffness (elasticity and viscosity) by applying vibration through a specialized probe (indenter).
Study Details
Researchers are trying to determine whether there is additional utility to using vibroelastography, a noninvasive ultrasound technique to evaluate for the presence of tissue fibrosis, in conjunction with standard penile duplex Doppler ultrasound to assess erectile function (recovery) after prostate cancer surgery.
Key Dates
- Start date
- Oct 2, 2023
- Status verified
- Jun 2026
- Primary completion
- Oct 31, 2028
- Completion
- Oct 31, 2028
Study Design
- Enrollment
- 10 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Ultrasound viscoelastography (UVE) in radical proctectomy recoverySubjects undergoing radical prostatectomy for prostate cancer disease as standard of care will have a ultrasound vibroelastography performed before surgery, 3 months, 6 months and 9 months post-prostatectomy.
Primary Outcome Measure
Change in Viscoelasticity [ Time Frame: Baseline, 3 months, 6 months and 9 months post-prostatectomy ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic in Rochester | Rochester | Minnesota | 55905 | Matt J. Ziegelmann, M.D. (PRINCIPAL_INVESTIGATOR) Xiaoming Zhang, Ph.D. (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Rochester, MN
By research site
Related Studies
- Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE TrialPHASE3 · Recruiting · NRG Oncology · Phoenix, Arizona
- Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET ImagingPHASE3 · Recruiting · ECOG-ACRIN Cancer Research Group · Anchorage, Alaska
- Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate CancerPHASE3 · Recruiting · NRG Oncology · Birmingham, Alabama
- Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate CancerPHASE3 · Recruiting · Curium US LLC · Homewood, Alabama